Graybug Vision, Inc. (NASDAQ:GRAY – Get Free Report)’s stock price traded up 3% during mid-day trading on Friday . The stock traded as high as $5.58 and last traded at $5.45. 8,939 shares changed hands during trading, an increase of 313% from the average session volume of 2,165 shares. The stock had previously closed at $5.29.
Graybug Vision Price Performance
The company has a market cap of $8.56 million, a P/E ratio of -0.22 and a beta of 1.20. The company has a 50 day moving average of $4.32 and a 200-day moving average of $3.86.
About Graybug Vision
Graybug Vision, Inc, a clinical-stage biopharmaceutical company, focuses on the development of medicines for the treatment of diseases of the retina and optic nerve. The company's lead product candidate is GB-102, an intravitreal injection of a microparticle depot formulation of sunitinib that is in Phase I/IIa and IIb clinical trials for the treatment of wet age-related macular degeneration, as well as in Phase IIa clinical trial to treat diabetic macular edema.
Featured Articles
- Five stocks we like better than Graybug Vision
- What is a Dividend Harvesting Strategy and How Can Investors Profit from it?
- MarketBeat Week in Review – 4/22 – 4/26
- What is MarketRank™? How to Use it
- 3 Stocks Leading the U.S. Agriculture Comeback
- 3 Stocks to Consider Buying in October
- How to Use Put Debit Spreads to Profit From Falling Stocks
Receive News & Ratings for Graybug Vision Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Graybug Vision and related companies with MarketBeat.com's FREE daily email newsletter.
